Randomised Phase II Trial of Olaparib, chemotherapy, or Olaparib and Cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol

MANSOURI A., MCGREGOR N., Dunn R., Dobbie S., HOLMES J., COLLINS L., NICUM S.

Type

Journal article

Journal

BMJ Open

Publisher

BMJ Publishing Group

Publication Date

17/12/2020

Permalink